TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
136,510
|
123,929
|
122,616 |
| Financial expenses |
1,293
|
2,055
|
1,706 |
| Earnings before taxes |
-7,574
|
-41,254
|
-23,942 |
| EBITDA |
9,774
|
-27,455
|
-13,672 |
| Total assets |
174,055
|
165,462
|
196,843 |
| Current assets |
86,101
|
70,181
|
67,173 |
| Current liabilities |
39,568
|
81,350
|
67,309 |
| Equity capital |
128,193
|
76,442
|
127,975 |
| - share capital |
155
|
152
|
142 |
| Employees (average) |
53
|
69
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.7%
|
46.2%
|
65.0% |
| Turnover per employee |
2,576
|
1,796
|
1,635 |
| Profit as a percentage of turnover |
-5.5%
|
-33.3%
|
-19.5% |
| Return on assets (ROA) |
-3.6%
|
-23.7%
|
-11.3% |
| Current ratio |
217.6%
|
86.3%
|
99.8% |
| Return on equity (ROE) |
-5.9%
|
-54.0%
|
-18.7% |
| Change turnover |
10,346
|
-7,387
|
-1,054 |
| Change turnover % |
8%
|
-6% | |
| Chg. No. of employees |
-16
|
-6
|
9 |
| Chg. No. of employees % |
-23%
|
-8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.